87 related articles for article (PubMed ID: 2074925)
1. [Cryoglobulinemia type II].
Madi N; Schifferli JA
Nephrologie; 1990; 11(4):237-41. PubMed ID: 2074925
[TBL] [Abstract][Full Text] [Related]
2. Defective immune adherence and elimination of hepatitis B surface antigen/antibody complexes in patients with mixed essential cryoglobulinemia type II.
Madi N; Steiger G; Estreicher J; Schifferli JA
J Immunol; 1991 Jul; 147(2):495-502. PubMed ID: 2071892
[TBL] [Abstract][Full Text] [Related]
3. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB
J Mol Recognit; 1999; 12(4):249-57. PubMed ID: 10440996
[TBL] [Abstract][Full Text] [Related]
4. Reduction of the complement activation capacity of soluble IgG aggregates and immune complexes by IgM-rheumatoid factor.
Doekes G; Schouten J; Cats A; Daha MR
Immunology; 1985 Jul; 55(3):555-64. PubMed ID: 4018839
[TBL] [Abstract][Full Text] [Related]
5. IgM-RF prevents complement-mediated inhibition of immune precipitation.
Mitchell WS; Naama JK; Veitch J; Whaley K
Immunology; 1984 Jul; 52(3):445-8. PubMed ID: 6745994
[TBL] [Abstract][Full Text] [Related]
6. The rheumatoid factor response in the etiology of mixed cryoglobulins associated with hepatitis C virus infection.
Sasso EH
Ann Med Interne (Paris); 2000 Feb; 151(1):30-40. PubMed ID: 10761560
[TBL] [Abstract][Full Text] [Related]
7. Circulating immune complexes and rheumatoid arthritis.
Faaber P; Rijke Schilder TP; Capel PJ; Koene RA
J Rheumatol; 1985 Oct; 12(5):849-53. PubMed ID: 3878875
[TBL] [Abstract][Full Text] [Related]
8. Mononuclear phagocyte system in SLE. II. A kinetic model of immune complex handling in systemic lupus erythematosus.
Meryhew NL; Kimberly RP; Messner RP; Runquist OA
J Immunol; 1986 Jul; 137(1):97-102. PubMed ID: 3486919
[TBL] [Abstract][Full Text] [Related]
9. The roles of IgG, IgM rheumatoid factor, and their complexes in the induction of polymorphonuclear leukocyte chemotactic factor from complement.
Wagner T; Abraham G; Baum J
J Clin Invest; 1974 Jun; 53(6):1503-11. PubMed ID: 4133792
[TBL] [Abstract][Full Text] [Related]
10. Circulating immune complexes in onchocerciasis.
Paganelli R; Ngu JL; Levinsky RJ
Clin Exp Immunol; 1980 Mar; 39(3):570-5. PubMed ID: 7379329
[TBL] [Abstract][Full Text] [Related]
11. Complement-mediated delay in immune complex clearance from the blood owing to reduced deposition outside the reticuloendothelial system.
Skogh T; Stendahl O
Immunology; 1983 May; 49(1):53-9. PubMed ID: 6404812
[TBL] [Abstract][Full Text] [Related]
12. Circulating immune complexes associated with decreased complement-mediated inhibition of immune precipitation in sera from patients with bacterial endocarditis.
Kerr MA; Wilton E; Naama JK; Whaley K
Clin Exp Immunol; 1986 Feb; 63(2):359-66. PubMed ID: 3698338
[TBL] [Abstract][Full Text] [Related]
13. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB
J Mol Recognit; 1999; 12(5):249-57. PubMed ID: 10777254
[TBL] [Abstract][Full Text] [Related]
14. The effect of human IgM rheumatoid factor on renal glomerular immune complex deposition in passive serum sickness in the mouse.
Ford PM; Kosataka I
Immunology; 1982 Aug; 46(4):761-8. PubMed ID: 6213554
[TBL] [Abstract][Full Text] [Related]
15. The kinetics of clearance of human antibody/dsDNA immune complexes from rabbit circulation. Effects of dsDNA size, rheumatoid factor, and reduction and alkylation of the antibodies.
Taylor RP; Kujala G; Edberg JC; Foreman P; Davis JS; Wright E
J Immunol; 1986 May; 136(10):3785-92. PubMed ID: 3701061
[TBL] [Abstract][Full Text] [Related]
16. Phagocytosis and degradation of DNA-antiDNA complexes by human phagocytes. Influence of rheumatoid factors.
Lamers MC; de Groot ER; Roos D
J Rheumatol; 1981; 8(6):880-8. PubMed ID: 7328563
[TBL] [Abstract][Full Text] [Related]
17. Detection and partial characterization of immune complexes in patients with rheumatoid arthritis plus Sjogren's syndrome and with Sjogren's syndrome alone.
Yoshinoya S; McDuffy S; Alarcon-Segovia D; Pope RM
Clin Exp Immunol; 1982 May; 48(2):339-47. PubMed ID: 6980743
[TBL] [Abstract][Full Text] [Related]
18. Detailed analysis of the E2-IgM complex in hepatitis C-related type II mixed cryoglobulinaemia.
Ferri S; Dal Pero F; Bortoletto G; Bianchi FB; Lenzi M; Alberti A; Gerotto M
J Viral Hepat; 2006 Mar; 13(3):166-76. PubMed ID: 16475992
[TBL] [Abstract][Full Text] [Related]
19. In situ immune complex formation in the mouse glomerulus: reactivity with human IgM rheumatoid factor and the effect on subsequent immune complex deposition.
Ford PM; Kosatka I
Clin Exp Immunol; 1983 Feb; 51(2):285-91. PubMed ID: 6340871
[TBL] [Abstract][Full Text] [Related]
20. Circulating immune complexes and complement in rheumatoid arthritis.
Duquesnoy B
Ann Biol Clin (Paris); 1984; 42(1):71-5. PubMed ID: 6375473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
